GlassScriptPhysician profile
Holly Rowe
NPI 1255582961
$10,803.01
in general payments reported to CMS, 2019-2025
50 companies · $2,029 in 2025
The $2,029 reported for 2025 was more than what 94% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,772 · 2022: $2,339 · 2023: $2,655 · 2024: $2,009 · 2025: $2,029.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,693.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,692.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,835.13 | 2021-2025 | |
| Lilly USA, LLC | $958.79 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Astrazeneca Pharmaceuticals LP | $900.49 | 2021-2025 | Airsupra, Breztri, Farxiga |
| Amgen INC. | $840.68 | 2021-2025 | Otezla, Repatha, Repatha |
| Novo Nordisk INC | $663.92 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Collegium Pharmaceutical, INC. | $513.08 | 2022-2025 | Belbuca, Xtampza |
| Otsuka America Pharmaceutical, INC. | $471.08 | 2021-2025 | Rexulti, Abilify Mycite |
| Bayer Healthcare Pharmaceuticals INC. | $465.77 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $463.11 | 2021-2024 | Xarelto |
| Glaxosmithkline, LLC. | $384.22 | 2021-2025 | Arexvy, Shingrix |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $321.76 | 2022-2025 | Xifaxan, Relistor |
| Pfizer INC. | $297.75 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $258.07 | 2021-2025 | Jardiance, Tradjenta |
| Kowa Pharmaceuticals America, INC. | $245.12 | 2021-2024 | Livalo, Seglentis, Zoryve |
| Idorsia Pharmaceuticals US INC | $167.55 | 2022-2024 | Quviviq |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $138.59 | 2022-2025 | Freestyle Libre 3 |
| Biohaven Pharmaceuticals, INC. | $137.56 | 2021 | |
| Novartis Pharmaceuticals Corporation | $128.99 | 2022-2023 | |
| Lundbeck LLC | $123.13 | 2023-2025 | Rexulti |
| Biohaven Pharmaceutical Holding Company LTD. | $121.25 | 2022 | |
| Almatica Pharma LLC | $118.56 | 2021-2025 | Loreev Xr |
| Sanofi-Aventis U.S. LLC | $92.45 | 2021-2025 | |
| Eisai INC. | $90.06 | 2021-2022 | |
| Antares Pharma, INC. | $87.27 | 2022-2024 | Xyosted |
| Daiichi Sankyo INC. | $86.24 | 2021-2024 | Injectafer |
| Merck Sharp & Dohme LLC | $65.42 | 2022-2023 | Belsomra |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $59.32 | 2022-2025 | Caplyta |
| Nevro Corp. | $58.48 | 2023 | Senza |
| Mylan Specialty L.P. | $57.13 | 2024 | Yupelri |
| Axsome Therapeutics, INC. | $55.67 | 2023 | Auvelity |
| Phathom Pharmaceuticals, INC. | $49.34 | 2024 | Voquezna |
| Exact Sciences Corporation | $48.68 | 2023-2024 | Cologuard Collection Kit |
| Medtronic, INC. | $46.75 | 2022-2024 | Intellis Adaptivestim |
| Sumitomo Pharma America, INC. | $40.68 | 2025 | Gemtesa |
| Radius Health, INC. | $40.35 | 2023 | Tymlos |
| Viiv Healthcare Company | $37.59 | 2024 | Apretude |
| Corcept Therapeutics | $35.76 | 2025 | Korlym |
| Virtus Pharmaceuticals LLC | $31.13 | 2021 | |
| Arbor Pharmaceuticals, INC. | $30.19 | 2021-2022 | |
| Intra-Sana Laboratories | $29.89 | 2025 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Acerus Pharmaceuticals Corporation | $27.30 | 2022 | |
| Kyowa Kirin, INC. | $26.06 | 2023 | Nourianz |
| Edwards Lifesciences Corporation | $24.00 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Amarin Pharma, INC. | $23.05 | 2021 | |
| Halozyme INC | $20.91 | 2023 | |
| Verity Pharmaceuticals INC. | $20.70 | 2025 | Tlando |
| Tolmar, INC. | $18.89 | 2025 | Jatenzo |
| Baxter Healthcare | $18.08 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Evoke Pharma, INC. | $14.67 | 2024 | |
| Redhill Biopharma INC. | $12.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Holly Rowe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.